- Beiträge: 687
Doris2460 antwortete auf Zink
20 Jan. 2024 17:50
- Doris2460
687 Beiträge seit
13 August 2022
13 August 2022
Weniger
Mehr
Leider kann ich den Text nicht übersetzten. Allerdings ist mir aufgefallen, er ist Copyright 2018, was ja in der MM Behandlung eine andere Welt ist.
Verstehe auch nicht, was dieser Artikel in diesem Tread soll, kann natürlich daran liegen, dass ich ihn nicht wirklich verstehe.
Verstehe auch nicht, was dieser Artikel in diesem Tread soll, kann natürlich daran liegen, dass ich ihn nicht wirklich verstehe.
Doris
Das Leben geht weiter, selbst wenn es humpelt
Bitte Anmelden oder Registrieren um der Konversation beizutreten.
Zink wurde erstellt von Max
20 Jan. 2024 16:51
- Max
- Autor
4 Beiträge seit
11 Januar 2024
11 Januar 2024
Weniger
Mehr
- Beiträge: 4
Studie aus PubMed
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation
Lorenzo Iovino 1 , Francesco Mazziotta 2 , Giovanni Carulli 2 , Francesca Guerrini 2 , Riccardo Morganti 3 , Valentina Mazzotti 3 , Fabrizio Maggi 4 , Lisa Macera 4 , Enrico Orciuolo 2 , Gabriele Buda 2 , Edoardo Benedetti 2 , Francesco Caracciolo 2 , Sara Galimberti 2 , Mauro Pistello 4 , Mario Petrini 2
Affiliations expand
PMID: 29747074 DOI: 10.1016/j.leukres.2018.04.016
Abstract
Introduction: Zinc plays an important role in thymic function and immune homeostasis. We performed a prospective clinical trial using a high-dose zinc oral supplementation to improve the immune reconstitution after hematopoietic stem cell transplant (HSCT).
Patients and methods: We enrolled 18 patients undergoing autologous HSCT for multiple myeloma. Nine patients were randomized to receive only a standard antimicrobial prophylaxis; whereas, nine patients received in addition 150 mg/day of zinc from day +5 to day +100 after transplant.
Results: CD4+ naïve lymphocytes and TRECs showed a significant increase from day +30 until day +100 only in the zinc-treated group. Moreover, the load of Torquetenovirus, a harmless virus that replicates in course of immunedepression, increased at day +100 only in the control group. No severe adverse events were reported during the zinc consumption.
Conclusion: First data from the ZENITH trial suggest that high-dose zinc supplementation is safe and may enhance the thymic reconstitution after HSCT. Registered: Clinicaltrials.gov (NCT03159845); and EUDRACT: 2014-28 004499-47.
Keywords: Bone marrow transplant; Digital PCR; Immune reconstitution; Immunesenescence; T cell; TTV; Thymus; Zinc.
Copyright © 2018 Elsevier Ltd. All rights reserved.
PubMed Disclaimer
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation
Lorenzo Iovino 1 , Francesco Mazziotta 2 , Giovanni Carulli 2 , Francesca Guerrini 2 , Riccardo Morganti 3 , Valentina Mazzotti 3 , Fabrizio Maggi 4 , Lisa Macera 4 , Enrico Orciuolo 2 , Gabriele Buda 2 , Edoardo Benedetti 2 , Francesco Caracciolo 2 , Sara Galimberti 2 , Mauro Pistello 4 , Mario Petrini 2
Affiliations expand
PMID: 29747074 DOI: 10.1016/j.leukres.2018.04.016
Abstract
Introduction: Zinc plays an important role in thymic function and immune homeostasis. We performed a prospective clinical trial using a high-dose zinc oral supplementation to improve the immune reconstitution after hematopoietic stem cell transplant (HSCT).
Patients and methods: We enrolled 18 patients undergoing autologous HSCT for multiple myeloma. Nine patients were randomized to receive only a standard antimicrobial prophylaxis; whereas, nine patients received in addition 150 mg/day of zinc from day +5 to day +100 after transplant.
Results: CD4+ naïve lymphocytes and TRECs showed a significant increase from day +30 until day +100 only in the zinc-treated group. Moreover, the load of Torquetenovirus, a harmless virus that replicates in course of immunedepression, increased at day +100 only in the control group. No severe adverse events were reported during the zinc consumption.
Conclusion: First data from the ZENITH trial suggest that high-dose zinc supplementation is safe and may enhance the thymic reconstitution after HSCT. Registered: Clinicaltrials.gov (NCT03159845); and EUDRACT: 2014-28 004499-47.
Keywords: Bone marrow transplant; Digital PCR; Immune reconstitution; Immunesenescence; T cell; TTV; Thymus; Zinc.
Copyright © 2018 Elsevier Ltd. All rights reserved.
PubMed Disclaimer
Bitte Anmelden oder Registrieren um der Konversation beizutreten.